US Stock MarketDetailed Quotes
EVFM Evofem Biosciences
- 0.009
- 0.000-3.69%
15min DelayClose Dec 20 16:00 ET
943.09KMarket Cap0.00P/E (TTM)
0.010High0.009Low841.74KVolume0.010Open0.010Pre Close7.66KTurnover0.84%Turnover Ratio0.19P/E (Static)100.33MShares0.06452wk High-0.01P/B943.06KFloat Cap0.00652wk Low--Dividend TTM100.33MShs Float23550.000Historical High--Div YieldTTM12.30%Amplitude0.006Historical Low0.009Avg Price1Lot Size
Evofem Biosciences Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 80.58%-459K | 23.63%-1.14M | 102.49%123K | 87.26%-8.97M | 97.40%-170K | 85.50%-2.36M | 94.40%-1.49M | 76.39%-4.94M | 51.99%-70.41M | 69.29%-6.53M |
| Net income from continuing operations | -103.58%-2.37M | 115.79%1.35M | -104.29%-4.81M | 169.07%52.98M | 74.64%-2.11M | -26.26%66.01M | 93.21%-8.56M | 92.62%-2.35M | 62.62%-76.7M | 83.83%-8.34M |
| Operating gains losses | 100.20%143K | -98.36%31K | 2,471.43%2.16M | -168.89%-68.15M | -95.26%47K | -376.09%-70.16M | -97.34%1.89M | -95.00%84K | --98.92M | --991K |
| Depreciation and amortization | -70.99%376K | 87.92%-40K | -92.12%59K | -12.95%1.78M | -94.77%67K | 418.40%1.3M | -232.40%-331K | 182.64%749K | 100.00%2.05M | 349.47%1.28M |
| Other non cash items | 304.33%1.32M | -52.43%627K | -0.18%564K | -44.37%1.8M | 5.77%568K | -320.07%-647K | -11.78%1.32M | -38.45%565K | -20.30%3.24M | -39.12%537K |
| Change In working capital | 201.94%631K | -100.10%-4K | 197.31%2.71M | -21.44%4.73M | -6.09%4.29M | -266.85%-619K | 189.12%3.85M | -151.60%-2.79M | -43.11%6.02M | -68.64%4.56M |
| -Change in receivables | 30.96%-776K | -114.10%-311K | 122.81%1.43M | -186.64%-4.61M | -94.98%584K | 79.41%-1.12M | 176.39%2.21M | -408.80%-6.28M | 198.90%5.32M | 581.27%11.64M |
| -Change in inventory | -12.89%-403K | -86.36%246K | 494.95%391K | 34.48%2.11M | 181.59%758K | -137.46%-357K | 129.22%1.8M | -113.11%-99K | 7,557.14%1.57M | -149.23%-929K |
| -Change in prepaid assets | -119.35%-154K | -124.43%-224K | -62.25%573K | 41.19%3.66M | -29.74%430K | -83.17%796K | 153.53%917K | 246.53%1.52M | -81.32%2.59M | -95.43%612K |
| -Change in payables and accrued expense | 1,674.55%1.95M | 214.70%320K | -86.32%364K | 339.38%5.05M | 145.05%2.56M | 344.44%110K | 44.64%-279K | -35.40%2.66M | -158.51%-2.11M | -367.55%-5.68M |
| -Change in other current liabilities | 127.27%12K | 95.61%-35K | 92.22%-46K | -9.16%-1.48M | 95.73%-46K | -122.92%-44K | -26,466.67%-797K | -26.82%-591K | 10.15%-1.35M | -147.02%-1.08M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 80.58%-459K | 23.63%-1.14M | 102.49%123K | 87.26%-8.97M | 97.40%-170K | 85.50%-2.36M | 94.40%-1.49M | 76.39%-4.94M | 51.99%-70.41M | 69.29%-6.53M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -509K | 0 | -366.67%-14K | 98.83%-4K | 0 | 0 | 99.41%-1K | 95.45%-3K | 87.32%-341K | 33.96%-35K |
| Net PPE purchase and sale | --0 | --0 | -366.67%-14K | 98.83%-4K | --0 | --0 | 99.41%-1K | 95.45%-3K | 88.40%-341K | 33.96%-35K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---509K | --0 | -366.67%-14K | 98.83%-4K | --0 | --0 | 99.41%-1K | 95.45%-3K | 87.32%-341K | 33.96%-35K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -53.32%998K | 91.62%1.14M | 0 | -92.29%4.78M | -77.33%340K | -45.82%2.14M | -98.56%597K | -88.76%1.7M | -31.70%61.94M | -84.80%1.5M |
| Net issuance payments of debt | -112.34%-262K | -71.08%144K | --0 | -20.01%4.49M | -85.07%224K | --2.12M | 108.45%498K | -83.60%1.64M | --5.61M | --1.5M |
| Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -60.38%32.3M | --0 |
| Proceeds from stock option exercised by employees | --0 | --0 | --0 | -98.85%290K | --116K | -99.67%14K | -99.53%99K | --61K | 5,433.11%25.23M | --0 |
| Net other financing activities | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 7.32%-1.2M | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -53.32%998K | 91.62%1.14M | --0 | -92.29%4.78M | -77.33%340K | -45.82%2.14M | -98.56%597K | -88.76%1.7M | -31.70%61.94M | -84.80%1.5M |
| Net cash flow | ||||||||||
| Beginning cash position | 8.81%692K | -55.08%689K | -87.86%580K | -64.85%4.78M | -95.83%410K | -97.14%636K | -80.16%1.53M | -64.85%4.78M | -81.19%13.59M | -60.69%9.84M |
| Current changes in cash | 113.27%30K | 100.33%3K | 103.36%109K | 52.38%-4.2M | 103.36%170K | 98.18%-226K | -106.18%-898K | 44.64%-3.24M | 84.98%-8.81M | 55.76%-5.07M |
| End cash Position | 76.10%722K | 8.81%692K | -55.08%689K | -87.86%580K | -87.86%580K | -95.83%410K | -97.14%636K | -80.16%1.53M | -64.85%4.78M | -64.85%4.78M |
| Free cash flow | 80.58%-459K | 23.68%-1.14M | 102.21%109K | 87.32%-8.97M | 97.41%-170K | 85.56%-2.36M | 94.43%-1.5M | 76.45%-4.94M | 52.71%-70.75M | 69.20%-6.57M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data